Special Delivery: The Latest from the Frontlines of Parkinson's Research

From the frontlines of Parkinson's disease (PD) research, The Michael J. Fox Foundation (MJFF) presents our 2018 Fall/Winter newsletter. Access the latest online to learn how the field is moving faster than ever toward critical Parkinson's disease (PD) breakthroughs. Highlights include: 

• CEO Todd Sherer breaks down the Foundation's approach to a cure and offers examples of how our investments in early-stage drug development are paying off for patients.
  
• Two MJFF-funded "rescue therapies" to alleviate movement symptomsduring "off" periods (when PD drugs aren't working optimally) are nearing pharmacy shelves.
   
• Rachel Dolhun, MD, Vice President of Medical Communications at MJFF, talks about how the development of common language around "off" time can help doctors, patients and caregivers improve treatment more broadly. 

Download the entire newsletter for more stories like these. And, join us in our urgent pursuit of a cure for Parkinson's. Donate today to help us continue to speed progress that can change millions of lives. Every dollar brings us closer to reporting from a world without PD.